Discounted for Volatility, Not for Quality
Bavarian Nordic trades at a discount for good reason. The market sees weak revenue growth—just 0.9% for FY25—and volatile earnings as the core risks. Vaccine launches are slow, and regulatory delays weigh on the story. No bargain until new products deliver.
Published by AssetNext · 2026-06-12
| Date | Signal | Peer score | Drawdown | 21d vs sector |
|---|---|---|---|---|
| 2026-06-08 | Profile and price weak | 46 | -26.4% | -31.6% |
| 2026-06-01 | Profile and price weak | 45 | -23.9% | -29.8% |
| 2026-05-26 | Profile and price weak | 45 | -20.7% | -10.7% |
Break down BAVA.CO's structural position across all peer dimensions with the interactive app.